C
CorMedix Inc. CRMD
$10.32 $0.545.52% NASDAQ
Recommendation
Prev Close
$9.78
Volume
2,153,247
Avg Vol (90D)
3,280,400
Market Cap
$770.56M
Dividend & Yield
--
52-Week Range
$5.60 - $17.43
P/E (TTM)
4.75
EPS (TTM)
$2.06
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Deep Track Capital, LP's Strategic Acquisition of Cormedix Inc Shares
12/4/2025 - GuruFocus
Bayer Stock Up as Government Backs Supreme Court Review in Roundup Case
12/3/2025 - Zacks Investment Research
CorMedix (CRMD, $9.78) Stochastic Oscillator left the oversold zone on December 02, 2025
12/3/2025 - Tickeron - Technical Analysis
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
12/3/2025 - Zacks Investment Research
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension
12/3/2025 - Zacks Investment Research
REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD
12/2/2025 - Zacks Investment Research
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business
12/2/2025 - Zacks Investment Research
MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study
12/2/2025 - Zacks Investment Research
JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis
12/2/2025 - Zacks Investment Research
ARCT Stock Plunges 59% in Three Months: Here's What You Need to Know
12/1/2025 - Zacks Investment Research
CorMedix (CRMD, $9.65) RSI Indicator left the oversold zone on November 26, 2025
11/27/2025 - Tickeron - Stocks
CorMedix (NASDAQ:CRMD) Trading Down 6% - Should You Sell?
11/26/2025 - MarketBeat
CorMedix (CRMD) Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration Filed
11/26/2025 - Simply Wall St
CorMedix (CRMD, $9.4) RSI Indicator left the oversold zone on November 25, 2025
11/26/2025 - Tickeron - Stocks
SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
11/25/2025 - Zacks Investment Research
CorMedix (CRMD, $9.82) RSI Indicator left the oversold zone on November 24, 2025
11/25/2025 - Tickeron - Stocks
BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study
11/24/2025 - Zacks Investment Research
FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer
11/24/2025 - Zacks Investment Research
Assessing CorMedix (CRMD) Valuation Following Recent Share Price Pullback
11/22/2025 - Simply Wall St
CorMedix (CRMD, $9.68) RSI Indicator left the oversold zone on November 21, 2025
11/22/2025 - Tickeron - Technical Analysis
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ...
11/21/2025 - GuruFocus
Q3 2025 CorMedix Inc Earnings Call Transcript
11/20/2025 - GuruFocus
AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results
11/20/2025 - Zacks Investment Research
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
11/20/2025 - Zacks Investment Research
CorMedix (NASDAQ:CRMD) Trading Up 2.6% - Time to Buy?
11/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$214.30M
EBITDA (TTM)
$108.20M
EBIT (TTM)
$103.95M
Net Income (TTM)
$162.50M
Balance Sheet
Total Assets (Q)
$750.86M
Total Debt (Q)
$148.92M
Total Liabilities (Q)
$376.73M
Book Value Per Share (Q)
$4.78
Cash Flow
Cash from Operations (TTM)
$74.97M
Cash from Investing (TTM)
-$312.03M
Cash from Financing (TTM)
$251.15M
Net Change in Cash (TTM)
$14.09M
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
1.18
7-Day Total Return
6.61%
30-Day Total Return
-11.42%
60-Day Total Return
-20.80%
90-Day Total Return
-13.86%
Year to Date Total Return
25.55%
1-Year Total Return
4.77%
2-Year Total Return
189.89%
3-Year Total Return
135.62%
5-Year Total Return
20.70%
52-week Low
Apr 07, 2025 - $5.60
52-week High
Jun 23, 2025 - $17.43
Valuation
Market Cap
$770.56M - Small Cap
Enterprise Value
$863.76M
Price/Sales (TTM)
3.93
Price/Book (Q)
2.05
Dividends and Shares
Shares Outstanding
86.21
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cormedix.com
Phone Number
908 517 9500
Address
300 Connell Drive
Berkeley Heights, NJ 07922
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed